PEG-400

PEG-400 is in medicines people take every day, and that record is real. It is a record for defined concentrations inside finished products, though, not for the neat liquid used as a general-purpose carrier.

The clearest safety-relevant fact is that it is not pharmacologically inert. In healthy volunteers it shortened small intestinal transit and moved the absorption of a co-administered drug by roughly a third, downward at larger amounts and upward at the smallest tested ^{[2] [3]}. For anyone dissolving something in it, that means the vehicle is an interaction rather than a blank, and it means an inconsistent amount of vehicle between doses will look like an inconsistent compound. At larger volumes the same osmotic behaviour is what makes polyethylene glycols laxative.

Given intravenously, the vehicle alone has a toxic dose. A repeated-dose study in rats using a combination vehicle of 5% N-methyl-2-pyrrolidone, 45% propylene glycol and 50% PEG-400 produced tremors, convulsions and death at 5 mL/kg, injection site injury without systemic toxicity at 2 mL/kg, and no discomfort or injury across 28 days of once-daily dosing at 1 mL/kg ^[10]. Marketed parenteral products built on PEG-400 do exist; busulfan for high-dose chemotherapy is solubilized in dimethylacetamide, PEG-400 and water, and that formulation came with hemolysis testing, tonicity work and accelerated stability data behind it ^[9]. A home preparation has none of that, and with an injected cosolvent the vehicle volume is what causes harm first.

On the intestinal barrier the news is better than expected. When twelve common solubilizing agents were compared in rats for their effects on intestinal membrane barrier function and membrane toxicity, the agents that markedly increased permeability of a marker compound were the bile salt sodium taurocholate and the surfactants Labrasol and Transcutol P; PEG-400 was not among them ^[11]. That is affirmative evidence that PEG-400 is gentler on the gut lining than surfactant-based solubilizers, which is a different claim from it being harmless.

Two practical hazards remain. PEG hypersensitivity is uncommon but clinically recognised, and anyone with a known polyethylene glycol allergy should treat PEG-400 as the same chemistry regardless of chain length. And grade matters more here than sentiment suggests: glycol solvents are the class in which contamination has historically killed people, so pharmaceutical grade with a certificate of analysis is the only sensible purchase.

Polyethylene glycols have been pharmaceutical excipients for most of a century, sold under the name macrogol in Europe and numbered by average molar mass. That number is the whole distinction inside the family. PEG-200 through PEG-600 are liquids and are used as solvents, while PEG-3350 and above are waxy solids used as ointment bases and, taken orally, as osmotic laxatives. PEG-400 sits at the useful middle of the liquid range, viscous but pourable and miscible with water in all proportions.

Its place in modern medicine is documented rather than assumed. The survey of what commercially available oral and injectable solution formulations actually contain lists PEG-400 alongside PEG-300, ethanol, propylene glycol and glycerin as one of the standard water-soluble organic solvents used to get poorly soluble drugs into solution ^[1], and it turns up inside real parenteral products such as the dimethylacetamide, PEG-400 and water vehicle developed for intravenous busulfan ^[9].

The glycol family also carries the most important cautionary tale in the history of pharmaceutical carriers. In 1937 a sulfanilamide preparation was dissolved in diethylene glycol, a different and toxic glycol, and more than a hundred people died. The drug was fine; the solvent killed them. That episode produced the 1938 Food, Drug, and Cosmetic Act and the modern requirement to establish that a product is safe before selling it, and diethylene glycol contamination of glycerin and propylene glycol has caused mass poisonings repeatedly since. The lesson belongs on this page specifically: the carrier is not the safe part of a preparation, and its supply chain deserves the same scrutiny as the active compound's.

Among people who formulate things themselves, PEG-400 has a reputation as the safe, boring option: not flammable, not volatile, not stinging, present in medicines everyone has taken. Most of that is fair. What is not fair is the assumption that follows, which is that adding PEG-400 to a preparation changes only whether the compound dissolves.

The published record contradicts that in two ways. Cosolvent formulations trade permeability for solubility in direct proportion, so the amount of PEG-400 in a preparation partly determines how much of the compound ever gets in ^{[6] [5]}. And PEG-400 acts on the gut directly, shortening small intestinal transit and moving a co-administered drug's absorption by roughly a third in healthy people, upward at a small amount and downward at larger ones ^{[2] [3]}.

Set against the other carriers here, its position is clear enough. It is the least aggressive of the three polar solvents toward gut lining, and it was not among the agents that damaged the intestinal membrane when twelve solubilizers were compared ^[11]. It is also the weakest solubilizer of the common cosolvents in at least one direct ranking, behind ethanol ^[13]. And it is the one most likely to be quietly doing something to absorption that gets mistaken for the compound working or not working. MCT oil is not a rival to it at all; that is a fat, on the other side of the polarity line entirely.